Thank you for reading!
basic
UPGRADE
Mon T W Th F
6 December, 2021
Sema4
presented by Catalent
Op­ti­miz­ing Oral Drug De­liv­ery us­ing Zy­dis® Oral­ly Dis­in­te­grat­ing Tablet Tech­nol­o­gy to Ad­dress Pa­tient Chal­lenges
news
AbbVie tacks on a new warning to Rinvoq label as safety frets crimp JAK class
ENDPOINTS NEWS
Adicet unveils early responses for off-the-shelf drug leveraging rare T cells. Will durability hold up?
ENDPOINTS NEWS
MarketingRx: Thankful for nurses: J&J's new campaign aims to reset pandemic clock back to gratitude
ENDPOINTS NEWS
Aeglea's engineered enzyme flops outcomes test in rare metabolic disease. Is reducing a key biomarker enough for an approval?
ENDPOINTS NEWS
Gilead recalls 2 lots of Veklury after investigation confirms complaint of glass particulates
ENDPOINTS NEWS
Keytruda wins 8th FDA approval of 2021, moving into adjuvant and pediatric melanoma settings
ENDPOINTS NEWS
Covid-19 roundup: Valneva defends vaccine in wake of unflattering booster study; Merck goes after Pfizer’s new antiviral — report
ENDPOINTS NEWS
Weekly: All about Omicron; We need more Covid antivirals; GSK snags Pfizer’s vaccine exec; Janet Woodcock’s future at FDA; and more
ENDPOINTS NEWS
Hedge Funds Suffer Big Losses on Biotech Rout
WSJ
Webinar: Nonviral production of allogenic CAR-Tscm Cells
In this webinar, learn about Poseida Therapeutics’ approach to transitioning from autologous to fully allogeneic CAR-T therapy manufacturing.
sponsored by Sartorius
in case you missed it
1.
Ex-Immunomedics CFO charged with insider trading, faces up to 20 years in prison after allegedly tipping off girlfriend and relatives of a PhIII success
ENDPOINTS NEWS
2.
AstraZeneca nixes $8B Sobi buyout over fears a former drug would be sold to rivals — report
ENDPOINTS NEWS
3.
Researchers move closer to deciphering blood clots from AstraZeneca, J&J's Covid-19 vaccines
ENDPOINTS NEWS
4.
Peer Review
Joseph Arron marches to the beat of his own drum at 23andMe; Ex-Voyager CFO joins Sek Kathiresan at Verve Therapeutics
ENDPOINTS NEWS
5.
Accelerated approval reforms need meaningful confirmatory trial improvements, professors write in Science
ENDPOINTS NEWS
6.
Janet Woodcock plots her future at FDA, with senior advisor role to fall back on if Califf wins confirmation
Endpoints News
7.
‘Just stupid stuff’: Logistics and lack of testing stymied finding the Omicron variant in the U.S.
STAT
8.
Pfizer CEO Albert Bourla hits out at the "rubbish" that has been published about him
BBC
9.
COVID shots are finally arriving, but Africa can't get them all into arms
Reuters
Endpoints Careers
Lead Manager / Associate Director of Statistical Genetics
Deep Genomics
Boston, MA, USA
Scientist - Protein Analytics
Adimab, LLC
Lebanon, NH, USA
Microfluidics Manufacturing Technician
Aspect Biosystems
Vancouver, BC, Canada
Clinical Operations Contractor
Astex Pharmaceuticals
Pleasanton, CA, USA
Recruit talent with Endpoints Careers
Contact Melissa Nazzaro: melissa@endpointsnews.com
Endpoints webinars
Dec 08
12:00pm ET
State of the union for advanced medicines
Precision Advance
Dec 09
2:00pm ET
Using external data to accelerate randomized controlled trials without introducing bias
Unlearn
Dec 13
2:30pm ET
Different approaches to process development and manufacturing in gene therapy
3M
Dec 14
12:00pm ET
Checkpoint inhibitors: the gut microbiome’s role in anti-tumor response
TD2
Dec 15
12:00pm ET
Enterprise R&D transformation case study: Genentech
Benchling
Dec 16
12:00pm ET
CQV strategies that increase speed-to-market for gene therapy
Project Farma
Endpoints at #ASH21
Kyle Blankenship will examine the latest cell and gene therapy R&D news out of ASH21 — sign up today.
sponsored by Endpoints News
Arsalan Arif
.

Good morning and welcome back! Please join us at 2pm ET tomorrow for Women in Biopharma R&D — it's our second annual event where you'll meet 20 top women leaders shaping drug development today. It's hosted by my colleagues Amber Tong and Nicole DeFeudis and we're expecting a big audience, absolutely no charge to attend live. (Premium subscribers will receive a link for on-demand access.) Use the link above to sign up and I hope to see you there. 

.
Arsalan Arif
Publisher & Founder, Endpoints News
@AKAarsalan
John Carroll
Editor & Founder
Arsalan Arif
Publisher & Founder
Shehla Shakoor
Managing Director
Igor Yavych
Chief Technical Officer
Mike Peck
Chief Revenue Officer
Valentin Manov
Creative Director
Kyle Blankenship
Managing Editor
Amber Tong
Senior Editor
Beth Snyder Bulik
Senior Editor
Zachary Brennan
Senior Editor
Jason Mast
Editor
Nicole DeFeudis
Editor
Max Gelman
Editor
Josh Sullivan
Associate Editor
Kathy Wong
Assistant Editor
Melissa Nazzaro
Sales Director
Cassidy Murphy
Sales Associate
Jaime Bruder
Sr. Operations Manager
Kara Thibault
Operations Manager
Jordan Collins
Operations
Lirra Selibio
Subscriptions
Dawn Cleveland
Controller
Alex Hoffman
Copy Editor
Amanda Florez
Executive Assistant
Alex Lefterov
Graphic Designer
DeAna Catoni
Operations Coordinator
Kari Abitbol
Director, Studio
Julie Notario
Sales Director
Rachel Wilson
Operations Coordinator
Mykola Chornyi
Developer
Derek Graf
Copy/Visuals Editor
Paul Schloesser
Associate Editor
Andriy Tomchyshyn
Lead Developer
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.